Llorenç Coll-Mulet - Concepedia

Author

Llorenç Coll-Mulet

Institut d'Investigació Biomédica de Bellvitge

Also Known As

L Coll-Mulet, Llorenç Coll-Mulet, Llorenç Coll-Mulet

Publications

810

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigació Biomédica de Bellvitge Universitat de Barcelona Bellvitge University Hospital Institut Català d'Oncologia

About

Llorenç Coll-Mulet is an author at Institut d'Investigació Biomédica de Bellvitge specializing in medicine, apoptosis, and cell death.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	320
2	Cell Biology	3	3	213
3	Natural Sciences	1	1	22
4	Biochemistry	1	1	22
5	Chemical Biology	1	1	22

Llorenç Coll-Mulet

Publications

777

Citations

H-Index

Page 1

	Year	Citations
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells Llorenç Coll-Mulet, Daniel Iglesias‐Serret, Antonio F. Santidrián, Blood	2006	235
Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme Ruth Villalonga-Planells, Llorenç Coll-Mulet, Fina Martínez‐Soler, PLoS ONE Human Glioblastoma MultiformeChemoprevention StrategyApoptosisCell DeathGlioma	2011	125
AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells Antonio F. Santidrián, Diana M. González‐Gironès, Daniel Iglesias‐Serret, Blood	2010	100
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells Clara Campàs, Ana M. Cosialls, Montserrat Barragán, Experimental Hematology Hematological MalignancyApoptosisImmunologyCell DeathBcl-2 Inhibitors	2006	85
Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells Daniel Iglesias‐Serret, Mercè de Frías, Antonio F. Santidrián, Leukemia Hematological MalignancyLymphoid NeoplasiaSurvival SignalsMalignant Blood DisorderApoptosis	2006	56
Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase Cβ Montserrat Barragán, Mercè de Frías, Daniel Iglesias‐Serret, Journal of Leukocyte Biology	2006	52
Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer Inês Cebola, Joaquín Custodio, Mar Muñoz, Clinical Epigenetics	2015	43
Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance Daniel Iglesias‐Serret, Maria Piqué, Montserrat Barragán, APOPTOSIS Hematological MalignancyMedicineMcl-1/noxa BalanceApoptosisCell Death	2009	32
Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells Alba Pérez‐Perarnau, Llorenç Coll-Mulet, Camila Rubio‐Patiño, Epigenetics	2011	27
Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity Aizpea Zubia, Santiago Ropero, Dorleta Otaegui, Oncogene Medicinal ChemistryBiochemistryMedicineNatural SciencesHistone Deacetylase Inhibitors	2009	22

Page 1